Clinical trial
Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery…
NCT00348491 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00348491 |
|---|---|
| Title | Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib |
| Official title | A Randomized, Double-blind, Double-dummy, Parallel Group, Single-center Study Evaluating the Analgesic Effect of Single Doses of Lumiracoxib 400 mg, Celecoxib 400 mg and Placebo in the Treatment of Post-dental Surgery Pain |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Lumiracoxib |
| Enrollment | 364 |
| Start date | Feb 1, 2006 |
| Primary completion | May 1, 2006 |
| First posted | Jul 4, 2006 |
| Last update posted | Feb 23, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: